New chairman for US PhRMA, David Brennan, sets out health reform vision

6 April 2009

The US Pharmaceutical Research and Manufacturers of America (PhRMA) has elected Anglo-Swedish drug major AstraZeneca's chief executive, David  Brennan, a US citizen, as board chairman replacing Richard Clark, the  CEO and president of US drug major Merck & Co. The handover was  effected at the PhRMA's meeting in San Antonio, Texas, where the new  chairman outlined his vision for the industry.

Mr Brennan began by noting that "we are in the midst of a deepening  global economic recession. Since the onset of this downturn in the  United States alone, over 4.4 million people have lost their jobs and,  in many instances, they've also lost their health insurance. It's not  hyperbole to say that before this recession is over millions more will  join the 47 million other Americans who do not have health insurance."

"Unsustainable" health costs by 2016

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight